Aim: To investigate the diagnostic efficacy and clinical application value of plasma endothelin-1 for diabetic retinopathy using receiver operating characteristic (ROC) curve analysis. Methods: This was a prospective investigational study. Funduscopy and fundus fluorescein angiography were used as gold standards for the diagnosis of diabetic retinopathy. Plasma endothelin-1 was measured in 96 diabetic patients with retinopathy (the case group) and 144 diabetic patients without retinopathy (the control group). Enumerative data were listed in a fourfold table. The measurement data were analyzed by Student’s t test and evaluated by cross-table analysis and ROC curve analysis. Results: (1) The plasma endothelin-1 concentration was higher in the case group than the control group (p = 0.002 < 0.01). (2) If the plasma endothelin-1 level of 162 pg/ml was adopted as the threshold for clinical diagnosis of diabetic retinopathy, the diagnostic sensitivity was 71.2%, diagnostic specificity 58% and diagnostic accuracy 66%. The positive predictive value was 69.81% and the negative predictive value 59.46%, and the positive likelihood ratio was 1.69 and the negative likelihood ratio 0.50. (3) When plasma endothelin-1 was used as a diagnostic criterion for diabetic retinopathy, the area under the ROC curve was 0.737. Conclusions: Plasma endothelin-1 plays an important role in the development and progression of diabetic retinopathy. When 162 pg/ml of plasma endothelin-1 was adopted as the diagnostic threshold, the diagnostic accuracy was medium; hence, the plasma endothelin-1 level can be used as the first step for diabetic retinopathy screening.

Keywords:
Receiver operating characteristic curve, Diabetic retinopathy, Plasma endothelin-1
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.